Global Nucleic Acid and Gene Therapies Market for Neuromuscular Disorders Poised for Growth, Expected to Reach US$19.52 Billion by 2033 at a 9.5% CAGR
The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders market would reach US$19.52 billion by 2033.